Literature DB >> 21531165

The implication of adiponectin and resistin in gastrointestinal diseases.

Elisavet K Tiaka1, Anastassios C Manolakis, Andreas N Kapsoritakis, Spyros P Potamianos.   

Abstract

Adiponectin and resistin, members of the adipokine family, are multi-task hormones involved in several disorders, including those of the alimentary tract. In the present review, eligible studies focusing on the role of adiponectin and resistin in gastrointestinal diseases are manifested together and classified according to anatomic criteria. In addition, similarities and common patterns have been recognized, ultimately revealing an inverse association: the down-regulation of adiponectin and up-regulation of resistin - both in vitro and in vivo - in gastrointestinal disorders, irrespective of their diverse nature - inflammatory, autoimmune or malignant - or anatomic position - esophageal, gastric, of the small intestine, colonic. Finally, a potential role for both adipokines in alimentary tract-related carcinogenesis has been identified, possibly representing a missing link between obesity and cancer.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531165     DOI: 10.1016/j.cytogfr.2011.04.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  13 in total

1.  Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction.

Authors:  Zhenyu Liu; Aiping Shi; Dong Song; Bing Han; Zhiru Zhang; Le Ma; Dongxu Liu; Zhimin Fan
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Role of resistin genetic variations in knee osteoarthritis pathogenesis, a cross sectional study.

Authors:  Syeda Kanwal Batool Naqvi; Iram Murtaza; Qamar Javed
Journal:  Mol Biol Rep       Date:  2019-03-22       Impact factor: 2.316

Review 3.  Obesity and colorectal cancer: role of adipokines in tumor initiation and progression.

Authors:  Silvia Riondino; Mario Roselli; Raffaele Palmirotta; David Della-Morte; Patrizia Ferroni; Fiorella Guadagni
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

4.  TH17, TH22 and Treg cells are enriched in the healthy human cecum.

Authors:  Martin J Wolff; Jacqueline M Leung; Michael Davenport; Michael A Poles; Ilseung Cho; P'ng Loke
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

5.  Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells.

Authors:  Yung-Yu Hsieh; Chien-Heng Shen; Wen-Shih Huang; Chih-Chien Chin; Yi-Hung Kuo; Meng Chiao Hsieh; Hong-Ren Yu; Te-Sheng Chang; Tseng-Hsi Lin; Yung-Wei Chiu; Cheng-Nan Chen; Hsing-Chun Kuo; Shui-Yi Tung
Journal:  J Biomed Sci       Date:  2014-06-14       Impact factor: 8.410

6.  Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients.

Authors:  Dorota Diakowska; Krystyna Markocka-Mączka; Piotr Szelachowski; Krzysztof Grabowski
Journal:  Dis Markers       Date:  2014-06-24       Impact factor: 3.434

Review 7.  Clinical significance of resistin expression in osteoarthritis: a meta-analysis.

Authors:  Xiao-Chuan Li; Feng Tian; Fei Wang
Journal:  Biomed Res Int       Date:  2014-10-29       Impact factor: 3.411

8.  Resistin reinforces interferon λ-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphisms.

Authors:  Ming-Ling Chang; Kung-Hao Liang; Cheng-Lung Ku; Chia-Chi Lo; Ya-Ting Cheng; Chen-Ming Hsu; Chau-Ting Yeh; Cheng-Tang Chiu
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

Review 9.  Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.

Authors:  Claudia Sanna; Chiara Rosso; Milena Marietti; Elisabetta Bugianesi
Journal:  Int J Mol Sci       Date:  2016-05-12       Impact factor: 5.923

10.  Comparison of abdominal adiposity and overall obesity in relation to risk of small intestinal cancer in a European Prospective Cohort.

Authors:  Yunxia Lu; Amanda J Cross; Neil Murphy; Heinz Freisling; Ruth C Travis; Pietro Ferrari; Verena A Katzke; Rudolf Kaaks; Åsa Olsson; Ingegerd Johansson; Frida Renström; Salvatore Panico; Valeria Pala; Domenico Palli; Rosario Tumino; Petra H Peeters; Peter D Siersema; H B Bueno-de-Mesquita; Antonia Trichopoulou; Eleni Klinaki; Christos Tsironis; Antonio Agudo; Carmen Navarro; María-José Sánchez; Aurelio Barricarte; Marie-Christine Boutron-Ruault; Guy Fagherazzi; Antoine Racine; Elisabete Weiderpass; Marc J Gunter; Elio Riboli
Journal:  Cancer Causes Control       Date:  2016-06-13       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.